


| Polio Vaccine Candidate Hoped To End Mutation Risk |
|
The Lancet. The vaccine, called nOPV2 and administered orally, is the first that works against poliovirus type 2, a mutated form of the virus that has been responsible for outbreaks in Africa and Asia. The development follows a surge in cases of type 2 poliovirus and amid warnings that millions of....
Posted: 2020-12-14 00:38:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.